Profil
Peder Møller Andersen currently works at Biosergen AB, as Chief Medical Officer from 2024.
Dr. Andersen also formerly worked at Biosergen AS, as Chief Executive Officer & Director, Forward Pharma GmbH, as Managing Director from 2009 to 2016, Astion Pharma A, as Vice President-Clinical Development from 2010 to 2012, and Forward Pharma A, as Chief Operating Officer in 2017.
Dr. Andersen received his doctorate degree in 1981 from the University of Copenhagen.
Aktive Positionen von Peder Andersen
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOSERGEN AB | Technik-/Wissenschafts-/F&E-Leiter | 31.01.2024 |
Ehemalige bekannte Positionen von Peder Andersen
| Unternehmen | Position | Ende |
|---|---|---|
| FORWARD PHARMA A/S | Vorstandsvorsitzender | 01.03.2017 |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Vorstandsvorsitzender | 01.01.2016 |
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Vorstandsvorsitzender | - |
Ausbildung von Peder Andersen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Biosergen AB
Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
















